Case study
The Healthcare Environment and the Value Chain in Morocco
Gain crucial insights into Morocco's pharmaceutical sector amidst new investment opportunities with expert consultations. BTHT facilitated one-hour sessions with Moroccan government health officials, leading industry figures, and international experts in active pharmaceutical ingredients. These consultations provided valuable information on the impact of compulsory health insurance on the pharmaceutical market, investment opportunities, and sector revitalization. The seamless execution of these consultations equipped the client with essential knowledge for developing a strategic business plan and capitalizing on emerging opportunities in Morocco’s evolving pharmaceutical landscape.
- North Africa
- Morocco
- Pharma
CHALLENGE
As the widespread introduction of compulsory health insurance in Morocco opens the door to new investment opportunities and a revitalisation of the pharmaceutical sector, a strategy consulting firm, working on behalf of their client, reached out to BTHT and would like to speak with Moroccan industry specialists and government bodies to identify and evaluate investment opportunities in Morocco's pharmaceutical industry.
BTHT APPROACH
After the research team conducted the kick-off meeting with the client, they identified target organizations and companies in Morocco. Contacts were established with officials from various government and private sector entities across different departments. Additionally, international industry experts with various specializations in the field of APIs (trade, manufacturing, plant-based APIs) from different countries of the world were reached out to. The profiles shared by BTHT with our client are as follows:
- Members of boards and leaders of Moroccan government health bodies (Executive Director of AMIP; Former President of LEMM/ Former GM of Sanofi;, Former VP of LEMM/ Market Access Head of Sanofi; Director at MAscir
- Managers of significant pharmaceutical companies in Morocco (Directors from Sothema and BOTTU, Former Director at GSK and Novartis, Former Marketing Excellence Head of GSK, Regulatory Affairs Director of BOTTU
- International industry experts specialized in active ingredients (trading, production)
BTHT team arranged and assisted the 1 hour consultations, and it was made sure to avoid any technical issue during the meetings.
OUTCOME
Our collaboration successfully connected the strategy consulting firm with key industry specialists in Morocco, enabling swift access to crucial insights on the pharmaceutical sector. This facilitated the development of a comprehensive business plan, positioning the firm strategically to capitalize on emerging investment opportunities in the context of compulsory health insurance. Our proactive approach expedited the process, ensuring timely acquisition of pertinent information for achieving project objectives.
Let's talk about your project
Reach our CEO Alexis Capelle directly or send us a message — we typically reply within one business day.